BrightSpring Health Services stock has surged nearly 59% year to date, significantly outperforming the Medical Services industry's 1.7% gain and the S&P 500's 12.2% rise. The company reported second-quarter 2026 revenues rose 23% year over year to $3.9 billion, while adjusted EBITDA jumped 44% with margin expansion. BrightSpring also raised its 2026 EBITDA outlook, reduced leverage to 2.15x, and continued expanding its Specialty Pharmacy and Provider Services businesses. The Zacks Consensus Estimate for 2026 and 2027 earnings per share implies year-over-year growth of 78% and 24.5%, respectively, to $1.78 and $2.21. Management expects roughly $600 million in operating cash flow this year as AI and automation initiatives support long-term profitability.
BrightSpring Health Services, Inc. Common StockQ2 revenues up 23%, adjusted EBITDA up 44%, raised 2026 outlook, and reduced leverage.
The Cooper Companies, Inc
Globus Medical
West Pharmaceutical Services Inc